JPS6111954B2 - - Google Patents

Info

Publication number
JPS6111954B2
JPS6111954B2 JP60036703A JP3670385A JPS6111954B2 JP S6111954 B2 JPS6111954 B2 JP S6111954B2 JP 60036703 A JP60036703 A JP 60036703A JP 3670385 A JP3670385 A JP 3670385A JP S6111954 B2 JPS6111954 B2 JP S6111954B2
Authority
JP
Japan
Prior art keywords
pyrrole
oxathiino
tetrahydro
oxo
general formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP60036703A
Other languages
English (en)
Japanese (ja)
Other versions
JPS60222484A (ja
Inventor
Kotoreru Kuroodo
Janmaaru Kuroodo
Parusoo Misheru
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rhone Poulenc Sante SA
Original Assignee
Rhone Poulenc Sante SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Sante SA filed Critical Rhone Poulenc Sante SA
Publication of JPS60222484A publication Critical patent/JPS60222484A/ja
Publication of JPS6111954B2 publication Critical patent/JPS6111954B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D497/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D497/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D497/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyrrole Compounds (AREA)
JP60036703A 1974-11-07 1985-02-27 １，４−オキサチイノ〔２，３−ｃ〕ピロ−ル誘導体の製造法 Granted JPS60222484A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7436962A FR2290208A1 (fr) 1974-11-07 1974-11-07 Nouveaux derives de l'oxathiinno(1,4)(2,3-c)pyrrole, leur preparation et les compositions qui les contiennent
FR7436962 1974-11-07

Publications (2)

Publication Number Publication Date
JPS60222484A JPS60222484A (ja) 1985-11-07
JPS6111954B2 true JPS6111954B2 (enExample) 1986-04-05

Family

ID=9144747

Family Applications (2)

Application Number Title Priority Date Filing Date
JP50132199A Expired JPS6029716B2 (ja) 1974-11-07 1975-11-05 １，４‐オキサチイノ〔２，３‐ｃ〕ピロール誘導体の製造法
JP60036703A Granted JPS60222484A (ja) 1974-11-07 1985-02-27 １，４−オキサチイノ〔２，３−ｃ〕ピロ−ル誘導体の製造法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP50132199A Expired JPS6029716B2 (ja) 1974-11-07 1975-11-05 １，４‐オキサチイノ〔２，３‐ｃ〕ピロール誘導体の製造法

Country Status (28)

Country Link
US (1) US4021554A (enExample)
JP (2) JPS6029716B2 (enExample)
AR (2) AR214045A1 (enExample)
AT (1) AT342603B (enExample)
AU (1) AU503381B2 (enExample)
BE (1) BE835324A (enExample)
CA (1) CA1054599A (enExample)
CH (2) CH608238A5 (enExample)
CS (1) CS191285B2 (enExample)
DD (1) DD122541A5 (enExample)
DE (1) DE2550163C2 (enExample)
DK (1) DK499175A (enExample)
ES (2) ES442442A1 (enExample)
FI (1) FI59251C (enExample)
FR (1) FR2290208A1 (enExample)
GB (1) GB1466829A (enExample)
HU (1) HU170500B (enExample)
IE (1) IE42030B1 (enExample)
IL (1) IL48422A (enExample)
LU (1) LU73737A1 (enExample)
NL (1) NL7512731A (enExample)
NO (1) NO143534C (enExample)
OA (1) OA05141A (enExample)
PH (1) PH14755A (enExample)
SE (1) SE419222B (enExample)
SU (2) SU576949A3 (enExample)
YU (2) YU281175A (enExample)
ZA (1) ZA756953B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1072557A (fr) * 1976-02-20 1980-02-26 Rhone-Poulenc Industries Derives du dithiepinno (1,4)(2,3-c) pyrrole, leur preparation et les compositions qui les contiennent
FR2525605A1 (fr) * 1982-04-22 1983-10-28 Rhone Poulenc Sante Nouveaux derives du dithiinno (1,4) (2,3-c) pyrrole, leur preparation et les medicaments qui les contiennent
FR2607504B1 (fr) * 1986-12-02 1989-01-27 Rhone Poulenc Sante Nouveaux derives de l'isoindolinone, leur preparation et les compositions pharmaceutiques qui les contiennent
PT2164501E (pt) * 2007-05-31 2016-06-02 Paradigm Biopharmaceuticals Ltd Xilanos sulfatados para tratamento ou profilaxia de doenças respiratórias

Also Published As

Publication number Publication date
SU576949A3 (ru) 1977-10-15
ES442442A1 (es) 1977-07-01
AR214045A1 (es) 1979-04-30
FR2290208B1 (enExample) 1978-07-28
FI753126A7 (enExample) 1976-05-08
FI59251B (fi) 1981-03-31
YU281175A (en) 1982-08-31
ZA756953B (en) 1976-10-27
YU108082A (en) 1982-08-31
DE2550163C2 (de) 1984-11-22
LU73737A1 (enExample) 1976-09-06
NL7512731A (nl) 1976-05-11
FI59251C (fi) 1981-07-10
IE42030L (en) 1976-05-07
DD122541A5 (enExample) 1976-10-12
JPS5170792A (en) 1976-06-18
NO143534B (no) 1980-11-24
DK499175A (da) 1976-05-08
NO753712L (enExample) 1976-05-10
JPS6029716B2 (ja) 1985-07-12
NO143534C (no) 1981-03-04
JPS60222484A (ja) 1985-11-07
US4021554A (en) 1977-05-03
GB1466829A (en) 1977-03-09
PH14755A (en) 1981-11-20
OA05141A (fr) 1981-01-31
BE835324A (fr) 1976-05-06
AR214400A1 (es) 1979-06-15
CH608808A5 (enExample) 1979-01-31
HU170500B (enExample) 1977-06-28
SU615860A3 (ru) 1978-07-15
AU8633275A (en) 1977-05-12
IL48422A (en) 1979-03-12
CA1054599A (fr) 1979-05-15
AU503381B2 (en) 1979-08-30
CH608238A5 (enExample) 1978-12-29
IL48422A0 (en) 1976-01-30
DE2550163A1 (de) 1976-05-20
CS191285B2 (en) 1979-06-29
IE42030B1 (en) 1980-05-21
AT342603B (de) 1978-04-10
SE419222B (sv) 1981-07-20
ES442441A1 (es) 1977-04-01
ATA848575A (de) 1977-08-15
FR2290208A1 (fr) 1976-06-04
SE7512476L (sv) 1976-05-10

Similar Documents

Publication Publication Date Title
US4399276A (en) 7-Substituted camptothecin derivatives
US3993656A (en) 1,8-Naphthyridine compounds
CA1331991C (en) Imidazo/2,1-b/benzothiazoles useful in the treatment of memory disorders and/or irritable conditions
FR2523582A1 (fr) Nouvelles 1h-pyrazolo(1,5-a)pyrimidines substituees, utiles notamment comme medicaments anti-inflammatoires et analgesiques, et procede pour leur preparation
JPH0146514B2 (enExample)
Verdecia et al. Synthesis of methyl 4-aryl-6-methyl-4, 7-dihydro-1 H-pyrazolo-[3, 4-b] pyridine-5-carboxylates from methyl 4-aryl-6-methyl-2-oxo-1, 2, 3, 4-tetrahydropyridine-5-carboxylates
FI62085B (fi) Analogifoerfarande foer framstaellning av nya terapeutiskt anvaendbara 4-oxo-1,6,7,8-tetrahydro-4h-pyrido-(1,2-a)pyrimidinderivat
JPS62147B2 (enExample)
JPS6111954B2 (enExample)
CA1173445A (en) Quinolone derivatives and their use as pharmaceuticals
US4053600A (en) Tricyclic 1,2,4-triazolo-quinazolines
JPH0699396B2 (ja) 新規オキサゾロピリジン誘導体
CA2049490A1 (en) Pyrrolobenzimidazoles, imidazobenzoxazinones and imidazoquinolones, process for their preparation and their use and preparations containing the compounds
WO1989002432A1 (fr) Derives de thienopyrimidine
Santilli et al. 8, 9, 10, 11-Tetrahydro-12H-benzo [5, 6] quinoxalino-[2, 3-e][1, 4] diazepin-12-ones. Examples of a New Heterocyclic Ring System
NO811667L (no) Fremgangsmaate ved fremstilling av substituerte pyrazinyl-1,2,4-oxadiazoler
JP2651912B2 (ja) イミダゾール誘導体、それらの製造法及び薬剤としての使用
JPS6028978A (ja) １，８−ナフチリジン誘導体
Tserng et al. Degradative ring opening of pyrido and pyrazino 3‐benzenesulfonyloxyuracils and their conversion to condensed pyrazolones and triazolones
US3494921A (en) 1,4-disubstituted pyridazino(4,5-d) pyridazines
US4452982A (en) Process for the preparation of nitrogen-bridgehead condensed pyrimidine compounds, and pharmaceutical compositions containing them
NO136840B (no) Analogifremgangsm}te til fremstilling av nye, terapeutisk aktive derivater av isoindolin.
JPS584034B2 (ja) ６−フエニル−ｓ−トリアゾロ〔４，３−ａ〕〔１，３，４〕ベンゾトリアゼピン類の製造法
US4281125A (en) Quinoline catalyzed synthesis of pyridazinone pharmaceutical intermediates
CA1049017A (en) Pyrrolo (3,4-b) pyridines and methods for their preparation